US Broker Ratings

KalVista Pharmaceuticals (KALV) Stock Analysis: Exploring the 100% Upside Potential

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to addressing unmet medical needs. The company is primarily focused..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Unveiling a 155% Potential Upside in Biotechnology

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a key player in the biotechnology sector, has captured the attention of investors with its significant potential upside. Boasting a market capitalization of $665.54 million,..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating a 10.23% Potential Upside Amidst Market Challenges

Community Health Systems, Inc. (NYSE: CYH) presents an intriguing case for investors considering the healthcare sector, particularly in the medical care facilities industry. As one of the prominent operators of..

Stoke Therapeutics (STOK) Stock Analysis: Unveiling Growth Potential with a 23.54% Upside

Stoke Therapeutics, Inc. (NASDAQ: STOK) is making waves in the biotechnology sector, drawing the attention of investors keen on capitalizing on its robust growth trajectory and innovative therapeutic approach. With..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating a 46.34% Potential Upside in the Healthcare Tech Sector

Weave Communications, Inc. (WEAV) is garnering significant attention from investors with its innovative approach to enhancing customer experience and payment solutions for small and medium-sized healthcare businesses. As the healthcare..

Cogent Biosciences, Inc. (COGT) Stock Analysis: A 28% Upside Potential in the Biotech Sector

Cogent Biosciences, Inc. (NASDAQ: COGT) is making waves in the biotechnology industry with its focused approach to precision therapies targeting genetically defined diseases. This Waltham, Massachusetts-based company is particularly noteworthy..

Oculis Holding AG (OCS) Stock Analysis: Unveiling a 68% Upside Potential for Investors

In the dynamic world of biotechnology, Oculis Holding AG (OCS) stands out as a promising player with its innovative approach to treating ophthalmic diseases. Headquartered in Zug, Switzerland, Oculis is..

Nuvation Bio Inc. (NUVB) Stock Analysis: 97% Potential Upside with Promising Oncology Pipeline

Nuvation Bio Inc. (NASDAQ: NUVB) is capturing investor interest with a compelling combination of substantial revenue growth and a promising clinical pipeline, despite its current financial challenges. As a clinical-stage..

ArriVent BioPharma, Inc. (AVBP): An Investor Outlook on Its 59.66% Potential Upside

ArriVent BioPharma, Inc. (AVBP), a promising player in the biotechnology sector, is capturing investor attention with its substantial potential upside and a robust portfolio of innovative cancer therapies. As a..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unpacking a Potential 210% Upside Amidst Biotech Innovations

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a trailblazer in the biotechnology sector, has captured investor attention with a notable potential upside of 210.41%, according to recent analyst ratings. As a commercial-stage..

iRadimed Corporation (IRMD): Investor Outlook on a Medical Device Innovator with a 15.7% Revenue Growth

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specializes in developing MRI-compatible medical devices. Headquartered in Orlando, Florida, the company has carved out a niche within the..

Butterfly Network, Inc. (BFLY) Stock Analysis: Examining the Potential 7.71% Upside in a Bullish Medical Device Market

Butterfly Network, Inc. (NASDAQ: BFLY) is making waves in the healthcare sector, particularly in the niche of medical devices. With a current market capitalization of $1.19 billion, Butterfly Network is..

Arcus Biosciences (RCUS): Investor Outlook Reveals 43% Upside Potential Amid Biotech Innovations

Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector with its promising cancer therapies. With a current market capitalization of $2.85 billion,..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: A Look at Potential 19.51% Upside in the Healthcare Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT) is positioning itself as a promising player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in El Monte, California, Fulgent Genetics..

Avadel Pharmaceuticals (AVDL) Stock Analysis: Navigating Potential Amidst a 54.9% Revenue Growth Surge

Avadel Pharmaceuticals plc (NASDAQ: AVDL) has been capturing the attention of investors within the healthcare sector, specifically those focusing on specialty and generic drug manufacturers. This Ireland-based biopharmaceutical company, with..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Growth and Valuation with a 3.34% Potential Upside

Phibro Animal Health Corporation (NASDAQ: PAHC) stands out in the healthcare sector as a key player in the drug manufacturers – specialty and generic industry. With a market capitalization of..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Biotech Gem with 65% Upside Potential

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a burgeoning name in the healthcare sector, is capturing the attention of investors with its promising prospects in the biotechnology industry. Specializing in innovative treatments..

Nutex Health Inc. (NUTX) Stock Report: Exploring a 56.82% Potential Upside in the Booming Healthcare Sector

Nutex Health Inc. (NASDAQ: NUTX) has emerged as a noteworthy player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.13 billion, Nutex..

Beta Bionics, Inc. (BBNX) Stock Analysis: A 92.67% Upside Potential for Innovative Diabetes Solutions

For investors seeking exposure to the cutting-edge healthcare sector, Beta Bionics, Inc. (NASDAQ: BBNX) offers a compelling opportunity with significant growth potential. This commercial-stage medical device company, based in Irvine,..

Intellia Therapeutics (NTLA) Stock Analysis: Exploring a 40% Upside Potential in Gene Editing Innovations

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a trailblazer in the biotechnology sector, is captivating investor attention with its promising gene editing technologies and substantial growth potential. Headquartered in Cambridge, Massachusetts, Intellia..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds